{"id":"W4390062445","doi":"10.1093/bjd/ljad497","title":"How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users’ guide","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eli Lilly Japan; Mitsubishi Tanabe Pharma Corporation; Genentech; National Jewish Health; Torii Pharmaceutical; University of Oxford; Taiho Pharmaceutical; Kyowa Kirin Pharmaceutical Development; Boehringer Ingelheim Japan; LEO Pharma; Castle Biosciences; Sun Pharma; Dermira; Pfizer; Incyte; Regeneron Pharmaceuticals; Amgen; Celgene; Valeant Pharmaceuticals International; Sanofi; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Outcome (game theory); Clinical trial; Atopic dermatitis; Medicine; Set (abstract data type); Alternative medicine; Sample (material); MEDLINE; Sample size determination; Family medicine; Medical physics; Core (optical fiber); Medical education; Computer science; Dermatology; Statistics; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.150009,0.004357452,0.006948973,0.01321014,0.001194815,0.008625524,0.006166555,0.0073047,0.09271608],"category_scores_gemma":[0.3679641,0.005187924,0.0107626,0.01288125,0.002437023,0.007134466,0.004673007,0.01043263,0.05685788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00263799,"about_ca_system_score_gemma":0.01329862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004677634,"about_ca_topic_score_gemma":0.008810418,"domain_scores_codex":[0.8598114,0.09066148,0.0341363,0.002887462,0.01152208,0.0009813361],"domain_scores_gemma":[0.5948544,0.3045746,0.01608506,0.02422547,0.05614966,0.004110772],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008241889,0.0001671429,0.001100947,0.01750206,0.000708127,0.0002523734,0.0008715336,0.001576764,0.0007977168,0.006722925,0.7635267,0.2059495],"study_design_scores_gemma":[0.002486882,0.0003617147,0.003573318,0.01660053,0.0006966352,0.0004687754,0.0004661361,0.004438494,0.0012814,0.03288406,0.9363071,0.0004350407],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.002345375,0.02637634,0.54839,0.05864686,0.009759513,0.112692,0.1465881,0.04149868,0.05370309],"genre_scores_gemma":[0.003876643,0.008756293,0.847257,0.01176958,0.001586517,0.09313504,0.01417555,0.006618863,0.01282445],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.150009,"threshold_uncertainty_score":0.7933328,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2650245791995647,"score_gpt":0.4130602091502216,"score_spread":0.1480356299506569,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}